Announcing Nominations for Scientific Prizes for Parkinson’s Disease in Israel

The Aufzien Family Center for the Prevention and Treatment of Parkinson’s Disease (APPD) will award two prizes through a new program in Parkinson’s Disease. APPD is committed to support excellence in fundamental and translational research into the causes, mechanisms, diagnosis, treatment and prevention of Parkinson’s Disease by awarding new scientific prizes to scientists in Israel – Established and Junior.

 

The APPD Scientific Prizes will honor major research discoveries. The Prizes will be awarded to investigators in recognition of the excellence and impact of his/her work in Parkinson’s Disease, based on their long term contribution.

 

The amount of the Prize is set to $7,000 USD for the Established Scientist Prize and $3,500 USD for the Junior Scientist Prize.

 

Established Scientist Prize: Ten or more years of experience in a tenure track position at a University or Institute. Position start before October 1, 2013. Junior Scientist Prize: Ten or less years of experience in a tenure track position at a University or Institute. Position start from and after October 1, 2013.

 

The Prizes are open to investigators in an Israeli University, hospital or institute holding a faculty position in a University as either M.D., Ph.D. or M.D./Ph.D. and still active in research/practice (Emeritus status not eligible). Candidates must be Israeli citizens and reside in Israel. Current members of the APPD Steering Committee are ineligible.

 

Nomination process

Nominations to the Prize may be submitted by a peer or self-nominations.
In case of self-nomination, letters must be sent directly from referees.

 

Nomination deadline: April 15, 2023

 

For policies and guidelines, see >>

 

For questions, contact Dr. Keren Shatzman e-mail: kersha@tauex.tau.ac.il

 

PDF grant call

 

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>